申请人:Shanghai Jemincare Pharmaceuticals Co., Ltd.
公开号:EP4043437A1
公开(公告)日:2022-08-17
The present invention belongs to the field of medicinal chemistry. Disclosed are a pyridine oxynitride, a preparation method therefor and the use thereof. Specifically, the present invention relates to a series of sodium ion channel blockers with a new structure, a preparation method therefor and the use thereof. The structure thereof is as shwon in general formula (I) below. The compounds or a stereoisomer, a racemate, a geometric isomer, a tautomer, a prodrug, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof and a pharmaceutical composition can be used for treating or/and preventing related diseases mediated by a sodium ion channel (NaV).
本发明属于药物化学领域。公开了一种吡啶氧硝化物、其制备方法及其用途。具体而言,本发明涉及一系列新结构的钠离子通道阻滞剂,其制备方法及其用途。其结构如下所示的通式(I)。该化合物或其立体异构体、外消旋体、几何异构体、互变异构体、前药、水合物、溶剂物或其药学上可接受的盐和药物组合物可用于治疗和/或预防由钠离子通道(NaV)介导的相关疾病。